Establishment of NAFLD Cohort and Development of Fibrosis Markers (NAFLD)
Establishment of Non-alcoholic Fatty Liver Disease Cohort and Development of Markers to Predict Histologic Progression of Liver Fibrosis
Sponsor: Seoul National University Boramae Hospital
Listed as NCT02206841, this observational or N/A phase trial focuses on Fibrosis of Liver and remains actively recruiting participants. Sponsored by Seoul National University Boramae Hospital, it has been updated 17 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
17 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Jun 2025 — Sep 2025 [monthly]
Recruiting
-
Sep 2024 — Jun 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 12 earlier versions
-
Jun 2022 — Dec 2023 [monthly]
Recruiting
-
Dec 2021 — Jun 2022 [monthly]
Recruiting
-
Apr 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Apr 2020 — Nov 2020 [monthly]
Recruiting
-
May 2019 — Apr 2020 [monthly]
Recruiting
-
Jun 2018 — May 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Seoul National University Boramae Hospital
For direct contact, visit the study record on ClinicalTrials.gov .